Cabaletta Bio, Inc.
USD3.58
-0.10 (-2.72%)
CEO
Steven A. Nichtberger
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.86
Prev. Close
$3.68
Day Low
$3.43
Day High
$3.93
52W Low
$1.26
52W High
$4.23
Market Cap
$0.58B
Volume
4.64M
| 175,000 |
| $3.30 |
| 2 Mar 2026 | Binder Gwendolyn | President, Science & Tech. | A-Award | Acquired | 225,000 | $3.30 |
| 2 Mar 2026 | Chang David J. | Chief Medical Officer | A-Award | Acquired | 225,000 | $3.30 |
| 2 Mar 2026 | Nichtberger Steven | director, officer: President & CEO | A-Award | Acquired | 674,000 | $3.30 |
| 2 Mar 2026 | Marda Anup | Chief Financial Officer | A-Award | Acquired | 225,000 | $3.30 |
| 21 Jan 2026 | Chang David J. | Chief Medical Officer | P-Purchase | Acquired | 8,800 | $2.26 |
| 21 Jan 2026 | Binder Gwendolyn | President, Science & Tech. | P-Purchase | Acquired | 11,312 | $2.19 |
| 21 Jan 2026 | Tomasello Shawn | director | P-Purchase | Acquired | 22,725 | $2.21 |
| 21 Jan 2026 | Gavel Steve | Chief Commercial Officer | P-Purchase | Acquired | 22,170 | $2.27 |